Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lucie Lorkova"'
Autor:
Lucie Lorkova, Michaela Scigelova, Tabiwang Ndipanquang Arrey, Ondrej Vit, Jana Pospisilova, Eliska Doktorova, Magdalena Klanova, Mahmudul Alam, Petra Vockova, Bokang Maswabi, Pavel Klener, Jiri Petrak
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135314 (2015)
Mantle cell lymphoma (MCL) is a chronically relapsing aggressive type of B-cell non-Hodgkin lymphoma considered incurable by currently used treatment approaches. Fludarabine is a purine analog clinically still widely used in the therapy of relapsed M
Externí odkaz:
https://doaj.org/article/934d78619f8049778d49fd8d7f250fbf
Autor:
Magdalena Klanova, Jiri Petrak, Lucie Lorkova, Ondrej Vit, Jan Zivny, Jana Pospisilova, Pavel Klener
Publikováno v:
International journal of molecular medicine. 31(5)
Mantle cell lymphoma (MCL) is a rare aggressive type of B-cell non-Hodgkin's lymphoma. Response to chemo- therapy tends to be short and virtually all patients sooner or later relapse. The prognosis of relapsed patients is extremely poor. The tumor ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5924340a8dba09b62932e4434f9fc05d
https://pubmed.ncbi.nlm.nih.gov/23503700
https://pubmed.ncbi.nlm.nih.gov/23503700
Autor:
Bruce A. Palfey, Anna Prem, Peter Macheroux, Andrea Wagner, Sonja Sollner, Markus Schober, Lucie Lorkova, Michael Groll
The proteasome has an essential function in the intracellular degradation of protein in eukaryotic cells. We found that the dimeric quinone reductase Lot6 uses the flavin mononucleotide (FMN)-binding site to bind to the 20S proteasome with a 1:2 stoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::138b897ca741bc13963eed56aaf8879d
https://europepmc.org/articles/PMC2613204/
https://europepmc.org/articles/PMC2613204/
Autor:
Tabiwang N. Arrey, Mahmudul Alam, Michaela Scigelova, Magdalena Klanova, Petra Vockova, Jiri Petrak, Bokang Maswabi, Eliska Doktorova, Ondrej Vit, Pavel Klener, Jana Pospisilova, Lucie Lorkova
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135314 (2015)
PLoS ONE
PLoS ONE
Mantle cell lymphoma (MCL) is a chronically relapsing aggressive type of B-cell non-Hodgkin lymphoma considered incurable by currently used treatment approaches. Fludarabine is a purine analog clinically still widely used in the therapy of relapsed M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::788cab7243e45fe47bde972d2e9bf742
https://doi.org/10.1371/journal.pone.0135314
https://doi.org/10.1371/journal.pone.0135314
Autor:
Jan Molinsky, Jiri Petrak, Francisco Hernandez, Magdalena Klanova, Pavel Klener, Martin Vokurka, Lucie Lorkova, Ondrej Vit, Cory Mavis, Jana Pospisilova, Bokang Maswabi
Publikováno v:
Blood. 122:3835-3835
Mantle cell lymphoma (MCL) is an aggressive type of B-cell non-Hodgkin lymphoma associated with poor prognosis. In recent years several studies brought evidence that implementation of high-dose cytarabine (ara-C) into induction therapy, e.g. by seque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d731bcfcce0e5bbad17f14e49690e0fa
https://doi.org/10.1182/blood.v122.21.3835.3835
https://doi.org/10.1182/blood.v122.21.3835.3835
Autor:
Jiri Petrak, Cory Mavis, Marek Trneny, Bokang Maswabi, Lucie Lorkova, Petra Vockova, Vojtech Kulvait, Pavel Klener, Dana Vejmelkova, Francisco Hernandez, Jan Molinsky, Radek Jaksa, Jana Pospisilova, Lucie Lateckova, Martin Vokurka, Ondrej Vit, Magdalena Klanova
Publikováno v:
Molecular Cancer
Background Mantle cell lymphoma (MCL) is an aggressive type of B-cell non-Hodgkin lymphoma associated with poor prognosis. Implementation of high-dose cytarabine (araC) into induction therapy became standard-of-care for all newly diagnosed younger MC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee74783cc0bb731583f80512ea494640
Autor:
David Sedmera, Ondrej Vit, Ludek Cervenka, Petr L. Jedelsky, Lucie Lorkova, Hynek Strnad, Jan Benes, Jana Pospisilova, Miroslava Šedinová, Jiri Petrak, Michal Kolar, Vojtech Melenovsky
Publikováno v:
Proteome Science, Vol 9, Iss 1, p 69 (2011)
Proteome Science
Proteome Science
Background Chronic hemodynamic overloading leads to heart failure (HF) due to incompletely understood mechanisms. To gain deeper insight into the molecular pathophysiology of volume overload-induced HF and to identify potential markers and targets fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::269b310e56ebe6e735adfdcf27fc4d6d